TP53 and cancer: The possible candidate pathways involved with the opposite direction between AD and cancers were found, including MYC targets, mTORC1 signaling, cell cycle checkpoints, DNA repair, unfolded protein response, proteasome, stabilization of p53, myogenesis, KRAS signaling, allograft rejection, and the complement cascade [44].